En español
NIDA

AIDS Research Program (ARP)

What We Do:

NIDA AIDS research program logo

Established in February 2005, NIDA's AIDS Research Program (ARP) supports the development, planning, and coordination of high priority research on HIV/AIDS and drug abuse within NIDA as well as across NIH Institutes and other DHHS agencies. ARP ensures that there an integrated vision and strategy to guide HIV/AIDS research throughout NIDA that is responsive to the evolving nature of HIV/AIDS disease among drug users in the U.S. and internationally.

Strategic Planning Workshops

The AIDS Research Program (ARP) at the National Institute on Drug Abuse (NIDA) convened a group of experts on November 9 and 14, 2018 to provide individual input on research gaps and opportunities for advancement of science at the intersection of HIV/AIDS and substance use, abuse, and addiction.

See the Strategic Planning Workshop reports

NIH Priorities for HIV and HIV-Related Research

An important new guidance setting NIH HIV/AIDS research priorities and guidelines for funding has been issued, and we wish to call this Notice to the attention of the NIDA HIV/AIDS research community http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html

NIH HIV/AIDS Research Priorities, 12-11-2015 (PDF, 751KB)

Also see NIH Director, Dr. Collins Statement on NIH Efforts to Focus Research to End the AIDS Pandemic (August 12, 2015)

Research and Training Opportunities:

Research Priorities:

Meetings:

Staff/Contacts:

Mailing Address:

AIDS Research Program
National Institute on Drug Abuse
6001 Executive Blvd, MSC 9581
Bethesda, MD 20892

This page was last updated January 2019

Get this Publication

    2018 Avenir Award

    Red ribbon to represent HIV/AIDS research and a DNA molecule to represent Genetics or Epigenetics research

    A proposal to study how drug users who are part of social networks influence their own communities has been selected for NIDA’s 2018 HIV/AIDS Avenir award (Press Announcement)

    Video

    Director Nora Volkow presenting at the AIDS 2012 conference

    New Frontiers in NIH AIDS Research at the XIX International AIDS Conference

    National HIV/AIDS Strategy